MetaADEDB 2.0 @ LMMD
Rivaroxaban
(KGFYHTZWPPHNLQ-AWEZNQCLSA-N)
Structure
SMILES
O=C1O[C@H](CN1c1ccc(cc1)N1CCOCC1=O)CNC(=O)c1ccc(s1)Cl
Type(s)
Approved
ATC code(s)
B01AF01
Molecular Formula:
C19H18ClN3O5S
Molecular Weight:
435.881
Log P:
3.0408
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
1
TPSA:
116.42
CAS Number(s):
366789-02-8
Synonym(s)
1.
Rivaroxaban
2.
5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide
3.
BAY 59-7939
4.
Xarelto
5.
BAY 59 7939
6.
BAY 597939
External Link(s)
MeSHD000069552
PubChem Compound9875401
BindingDB7840
12996
ChEBI68579
CHEMBLCHEMBL198362
DrugBankDB06228
DrugCentral4182
IUPHAR/BPS Guide to PHARMACOLOGY6388
KEGGdr:D07086
Therapeutic Target DatabaseD0KG3R
ZINC3964126
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Cerebrovascular accidentFAERS: 2794
Canada Vigilance: 108
Canada Vigilance
US FAERS
2Pulmonary EmbolismFAERS: 2614
Canada Vigilance: 147
Canada Vigilance
US FAERS
3Deep Vein ThrombosisFAERS: 2386
Canada Vigilance: 104
Canada Vigilance
US FAERS
4EpistaxisFAERS: 2291
Canada Vigilance: 113
Canada Vigilance
SIDER
US FAERS
5Adverse eventFAERS: 1824
Canada Vigilance: 1
Canada Vigilance
US FAERS
6ThrombosisFAERS: 1517
Canada Vigilance: 37
Canada Vigilance
US FAERS
7Drug ineffectiveFAERS: 1343
Canada Vigilance: 86
Canada Vigilance
US FAERS
8Drug dose omissionFAERS: 876US FAERS
9Drug prescribing errorFAERS: 872US FAERS
10Incorrect dose administeredFAERS: 854
Canada Vigilance: 10
Canada Vigilance
US FAERS
11Acute kidney injuryFAERS: 812
Canada Vigilance: 5
Canada Vigilance
US FAERS
12MenorrhagiaFAERS: 748
Canada Vigilance: 32
Canada Vigilance
SIDER
US FAERS
13Cerebral InfarctionFAERS: 706
Canada Vigilance: 3
Canada Vigilance
US FAERS
14HeadacheFAERS: 620
Canada Vigilance: 13
Canada Vigilance
SIDER
US FAERS
15DizzinessFAERS: 609
Canada Vigilance: 16
Canada Vigilance
SIDER
US FAERS
16Inappropriate schedule of drug administrationFAERS: 590US FAERS
17Blood urine presentFAERS: 528
Canada Vigilance: 34
Canada Vigilance
US FAERS
18FatigueFAERS: 475
Canada Vigilance: 14
Canada Vigilance
SIDER
US FAERS
19AlopeciaFAERS: 440
Canada Vigilance: 2
Canada Vigilance
US FAERS
20AstheniaFAERS: 415
Canada Vigilance: 13
Canada Vigilance
SIDER
US FAERS
21MalaiseFAERS: 400
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
22Myocardial InfarctionFAERS: 379
Canada Vigilance: 8
Canada Vigilance
US FAERS
23NauseaFAERS: 373
Canada Vigilance: 13
Canada Vigilance
SIDER
US FAERS
24Product use in unapproved indicationFAERS: 339
Canada Vigilance: 5
Canada Vigilance
US FAERS
25PruritusFAERS: 337
Canada Vigilance: 11
Canada Vigilance
SIDER
US FAERS
26Atrial FibrillationFAERS: 329
Canada Vigilance: 5
Canada Vigilance
US FAERS
27Peripheral swellingFAERS: 326
Canada Vigilance: 10
Canada Vigilance
US FAERS
28PainFAERS: 314
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
29Respiratory FailureFAERS: 293
Canada Vigilance: 1
Canada Vigilance
US FAERS
30Product use issueFAERS: 290
Canada Vigilance: 8
Canada Vigilance
US FAERS
31PneumoniaFAERS: 286
Canada Vigilance: 5
Canada Vigilance
US FAERS
32Atrial thrombosisFAERS: 280
Canada Vigilance: 3
Canada Vigilance
US FAERS
33Back PainFAERS: 256
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
34ArthralgiaFAERS: 248
Canada Vigilance: 13
Canada Vigilance
US FAERS
35Chest PainFAERS: 245
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
36ThrombocytopeniaFAERS: 237
Canada Vigilance: 9
Canada Vigilance
US FAERS
37Embolic strokeFAERS: 222
Canada Vigilance: 9
Canada Vigilance
US FAERS
38VomitingFAERS: 217
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
39HypotensionFAERS: 214
Canada Vigilance: 10
Canada Vigilance
SIDER
US FAERS
40Prescribed underdoseFAERS: 201
Canada Vigilance: 1
Canada Vigilance
US FAERS
41Abdominal PainFAERS: 195
Canada Vigilance: 12
Canada Vigilance
SIDER
US FAERS
42Creatinine renal clearance decreasedFAERS: 192
Canada Vigilance: 14
Canada Vigilance
US FAERS
43MyalgiaFAERS: 175
Canada Vigilance: 3
Canada Vigilance
US FAERS
44SyncopeFAERS: 174
Canada Vigilance: 10
Canada Vigilance
SIDER
US FAERS
45EcchymosisFAERS: 172SIDER
US FAERS
46Urinary tract infectionFAERS: 170
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
47Wrong technique in product usage processFAERS: 167
Canada Vigilance: 3
Canada Vigilance
US FAERS
48treatment failureFAERS: 159
Canada Vigilance: 1
Canada Vigilance
US FAERS
49Feeling abnormalFAERS: 153
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
50Weight decreasedFAERS: 144
Canada Vigilance: 2
Canada Vigilance
US FAERS
51SepsisFAERS: 143
Canada Vigilance: 3
Canada Vigilance
US FAERS
52Abdominal discomfortFAERS: 140
Canada Vigilance: 3
Canada Vigilance
US FAERS
53Acute respiratory failureFAERS: 138US FAERS
54Pericardial effusionFAERS: 138
Canada Vigilance: 1
Canada Vigilance
US FAERS
55Product dose omissionFAERS: 138
Canada Vigilance: 7
Canada Vigilance
US FAERS
56UrticariaFAERS: 136
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
57EmbolismFAERS: 135US FAERS
58AnxietyFAERS: 128
Canada Vigilance: 4
Canada Vigilance
US FAERS
59Medication ErrorFAERS: 125
Canada Vigilance: 1
Canada Vigilance
US FAERS
60Blood creatinine increasedFAERS: 121
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
61Cardiac ArrestFAERS: 113
Canada Vigilance: 7
Canada Vigilance
US FAERS
62ChromaturiaFAERS: 113
Canada Vigilance: 9
Canada Vigilance
US FAERS
63SwellingFAERS: 111
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
64ErythemaFAERS: 99
Canada Vigilance: 5
Canada Vigilance
US FAERS
65HemiparesisFAERS: 97
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
66HypersensitivityFAERS: 97
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
67Cardiac TamponadeFAERS: 95US FAERS
68Joint swellingFAERS: 93
Canada Vigilance: 6
Canada Vigilance
US FAERS
69Memory impairmentFAERS: 93US FAERS
70Wrong technique in drug usage processFAERS: 89US FAERS
71Gastric ulcerFAERS: 88
Canada Vigilance: 3
Canada Vigilance
US FAERS
72Pulmonary thrombosisFAERS: 88
Canada Vigilance: 4
Canada Vigilance
US FAERS
73ConstipationFAERS: 86
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
74Visual ImpairmentFAERS: 84
Canada Vigilance: 8
Canada Vigilance
US FAERS
75Septic ShockFAERS: 83
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
76General physical health deteriorationFAERS: 82
Canada Vigilance: 2
Canada Vigilance
US FAERS
77OverdoseFAERS: 82
Canada Vigilance: 3
Canada Vigilance
US FAERS
78Acute myocardial infarctionFAERS: 81
Canada Vigilance: 1
Canada Vigilance
US FAERS
79Sudden deathFAERS: 80OFFSIDES
US FAERS
80Venous ThrombosisFAERS: 80US FAERS
81PalpitationsFAERS: 77
Canada Vigilance: 2
Canada Vigilance
US FAERS
82PetechiaeFAERS: 77
Canada Vigilance: 1
Canada Vigilance
US FAERS
83NephrolithiasisFAERS: 74
Canada Vigilance: 1
Canada Vigilance
US FAERS
84Increased tendency to bruiseFAERS: 73
Canada Vigilance: 3
Canada Vigilance
US FAERS
85AphasiaFAERS: 72
Canada Vigilance: 6
Canada Vigilance
US FAERS
86ArthritisFAERS: 72
Canada Vigilance: 2
Canada Vigilance
US FAERS
87InfectionFAERS: 71
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
88TachycardiaFAERS: 71
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
89Product label issueFAERS: 70US FAERS
90Extra dose administeredFAERS: 69US FAERS
91VertigoFAERS: 69
Canada Vigilance: 1
Canada Vigilance
US FAERS
92Chest discomfortFAERS: 68
Canada Vigilance: 1
Canada Vigilance
US FAERS
93NasopharyngitisFAERS: 67US FAERS
94DyspepsiaFAERS: 66
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
95Splenic RuptureFAERS: 64
Canada Vigilance: 3
Canada Vigilance
US FAERS
96LacerationFAERS: 63US FAERS
97Limb injuryFAERS: 63
Canada Vigilance: 5
Canada Vigilance
US FAERS
98DiverticulitisFAERS: 62
Canada Vigilance: 3
Canada Vigilance
US FAERS
99DehydrationFAERS: 61
Canada Vigilance: 2
Canada Vigilance
US FAERS
100Blood glucose increasedFAERS: 58
Canada Vigilance: 1
Canada Vigilance
US FAERS
101GastritisFAERS: 58
Canada Vigilance: 3
Canada Vigilance
US FAERS
102TremorFAERS: 57US FAERS
103AbasiaFAERS: 55US FAERS
104CellulitisFAERS: 55US FAERS
105Musculoskeletal PainFAERS: 55
Canada Vigilance: 2
Canada Vigilance
US FAERS
106Product packaging quantity issueFAERS: 55US FAERS
107BlindnessFAERS: 54
Canada Vigilance: 2
Canada Vigilance
US FAERS
108ShockFAERS: 53
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
109DysarthriaFAERS: 52
Canada Vigilance: 1
Canada Vigilance
US FAERS
110LethargyFAERS: 52
Canada Vigilance: 2
Canada Vigilance
US FAERS
111Occult blood positiveFAERS: 52
Canada Vigilance: 1
Canada Vigilance
US FAERS
112UlcerFAERS: 52
Canada Vigilance: 5
Canada Vigilance
US FAERS
113HemiplegiaFAERS: 51
Canada Vigilance: 6
Canada Vigilance
US FAERS
114Unevaluable eventFAERS: 51
Canada Vigilance: 4
Canada Vigilance
US FAERS
115GoutFAERS: 50
Canada Vigilance: 2
Canada Vigilance
US FAERS
116PurpuraFAERS: 49
Canada Vigilance: 1
Canada Vigilance
US FAERS
117Therapy cessationFAERS: 49
Canada Vigilance: 1
Canada Vigilance
US FAERS
118Therapeutic procedureFAERS: 48US FAERS
119Transaminases increasedFAERS: 48OFFSIDES
US FAERS
120Alanine Aminotransferase IncreasedFAERS: 47
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
121DementiaFAERS: 46
Canada Vigilance: 1
Canada Vigilance
US FAERS
122DysgeusiaFAERS: 46US FAERS
123Embolic cerebral infarctionFAERS: 46US FAERS
124Diabetes MellitusFAERS: 44
Canada Vigilance: 1
Canada Vigilance
US FAERS
125Intentional product misuseFAERS: 43US FAERS
126SomnolenceFAERS: 43
Canada Vigilance: 4
Canada Vigilance
US FAERS
127Urinary RetentionFAERS: 43
Canada Vigilance: 4
Canada Vigilance
US FAERS
128Burning sensationFAERS: 42
Canada Vigilance: 1
Canada Vigilance
US FAERS
129Cerebellar infarctionFAERS: 42US FAERS
130High frequency ablationFAERS: 42US FAERS
131Tooth ExtractionFAERS: 41
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
132AmnesiaFAERS: 40US FAERS
133DiscomfortFAERS: 40
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
134Rash erythematousFAERS: 40
Canada Vigilance: 1
Canada Vigilance
US FAERS
135Tumour haemorrhageFAERS: 40
Canada Vigilance: 1
Canada Vigilance
US FAERS
136InfarctionFAERS: 39US FAERS
137Aspartate Aminotransferase IncreasedFAERS: 38
Canada Vigilance: 2
Canada Vigilance
US FAERS
138Cardiac ablationFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
139CataractFAERS: 38US FAERS
140Duodenal UlcerFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
141Gamma-Glutamyltransferase IncreasedFAERS: 38SIDER
US FAERS
142Gastrointestinal angiodysplasia haemorrhagicFAERS: 38US FAERS
143Maternal exposure during pregnancyFAERS: 38
Canada Vigilance: 3
Canada Vigilance
US FAERS
144PancreatitisFAERS: 38
Canada Vigilance: 3
Canada Vigilance
US FAERS
145Unresponsive to stimuliFAERS: 38
Canada Vigilance: 2
Canada Vigilance
US FAERS
146BronchitisFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
147Peripheral embolismFAERS: 37
Canada Vigilance: 2
Canada Vigilance
US FAERS
148Coronary Artery DiseaseFAERS: 36
Canada Vigilance: 2
Canada Vigilance
US FAERS
149HepatitisFAERS: 36
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
150Contraindicated product administeredFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
151PallorFAERS: 35
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
152Venous thrombosis limbFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
153Blood blisterFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
154TinnitusFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
155Disseminated Intravascular CoagulationFAERS: 33
Canada Vigilance: 2
Canada Vigilance
US FAERS
156Drug administration errorFAERS: 33US FAERS
157Respiratory distressFAERS: 33US FAERS
158AngioedemaFAERS: 32
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
159ChillsFAERS: 32US FAERS
160Inappropriate schedule of product administrationFAERS: 32
Canada Vigilance: 2
Canada Vigilance
US FAERS
161Neck PainFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
162Pelvic venous thrombosisFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
163ToothacheFAERS: 32
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
164Angina PectorisFAERS: 31SIDER
US FAERS
165CystitisFAERS: 31
Canada Vigilance: 4
Canada Vigilance
US FAERS
166DiverticulumFAERS: 31
Canada Vigilance: 2
Canada Vigilance
US FAERS
167Drug dispensing errorFAERS: 31US FAERS
168PancytopeniaFAERS: 31
Canada Vigilance: 3
Canada Vigilance
US FAERS
169Therapeutic response unexpectedFAERS: 31US FAERS
170Thrombotic strokeFAERS: 31
Canada Vigilance: 3
Canada Vigilance
US FAERS
171ArthropathyFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
172Limb discomfortFAERS: 30
Canada Vigilance: 3
Canada Vigilance
US FAERS
173PresyncopeFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
174Product size issueFAERS: 30US FAERS
175ThrombocytosisFAERS: 30
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
176jaundiceFAERS: 30
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
177Arterial thrombosisFAERS: 29
Canada Vigilance: 2
Canada Vigilance
US FAERS
178HydrocephalusFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
179Intentional product use issueFAERS: 29
Canada Vigilance: 3
Canada Vigilance
US FAERS
180VasculitisFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
181Antiphospholipid SyndromeFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
182Cerebral ThrombosisFAERS: 28US FAERS
183InflammationFAERS: 28
Canada Vigilance: 4
Canada Vigilance
US FAERS
184Cerebral artery occlusionFAERS: 27US FAERS
185Joint injuryFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
186Product physical issueFAERS: 27US FAERS
187Suicide attemptFAERS: 27US FAERS
188Suspected counterfeit productFAERS: 27US FAERS
189White blood cell count decreasedFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
190Accidental overdoseFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
191Aortic AneurysmFAERS: 26US FAERS
192Fibrin D dimer increasedFAERS: 26US FAERS
193InfluenzaFAERS: 26US FAERS
194Product packaging issueFAERS: 26US FAERS
195Product quality issueFAERS: 26US FAERS
196Pulmonary HypertensionFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
197colonoscopyFAERS: 26US FAERS
198FlatulenceFAERS: 25US FAERS
199Hypertensive crisisFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
200HypokinesiaFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
201Mental status changesFAERS: 25OFFSIDES
US FAERS
202Musculoskeletal stiffnessFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
203NervousnessFAERS: 25US FAERS
204SinusitisFAERS: 25SIDER
US FAERS
205Skin UlcerFAERS: 25US FAERS
206Subgaleal haematomaFAERS: 25US FAERS
207ThrombophlebitisFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
208Toxicity to various agentsFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
209AcneFAERS: 24US FAERS
210Acute Coronary SyndromeFAERS: 24
Canada Vigilance: 2
Canada Vigilance
US FAERS
211Atrial FlutterFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
212Blood count abnormalFAERS: 24US FAERS
213Cardiac ventricular thrombosisFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
214Dry skinFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
215Incorrect drug administration durationFAERS: 24US FAERS
216Peripheral artery thrombosisFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
217Product lot number issueFAERS: 24US FAERS
218AneurysmFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
219DysuriaFAERS: 23
Canada Vigilance: 2
Canada Vigilance
US FAERS
220Hip surgeryFAERS: 23US FAERS
221LeukopeniaFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
222Lip swellingFAERS: 23
Canada Vigilance: 2
Canada Vigilance
US FAERS
223Mallory-Weiss SyndromeFAERS: 23US FAERS
224Mental impairmentFAERS: 23
Canada Vigilance: 2
Canada Vigilance
US FAERS
225DiplopiaFAERS: 22US FAERS
226Immune thrombocytopenic purpuraFAERS: 22US FAERS
227NeutropeniaFAERS: 22US FAERS
228Oropharyngeal painFAERS: 22SIDER
US FAERS
229Product prescribing issueFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
230nervous system disorderFAERS: 22
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
231AgitationFAERS: 21
Canada Vigilance: 3
Canada Vigilance
US FAERS
232MetrorrhagiaFAERS: 21US FAERS
233PericarditisFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
234PneumothoraxFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
235Skin lesionFAERS: 21US FAERS
236Thrombosis in deviceFAERS: 21US FAERS
237Carotid artery occlusionFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
238EpilepsyFAERS: 20US FAERS
239Retinal DetachmentFAERS: 20US FAERS
240Skin necrosisFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
241Stevens-Johnson SyndromeFAERS: 20
Canada Vigilance: 1
25811541CTD
SIDER
Canada Vigilance
US FAERS
242Antiphospholipid antibodies positiveFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
243Eye painFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
244Feeling ColdFAERS: 19US FAERS
245Flank PainFAERS: 19US FAERS
246Renal painFAERS: 19US FAERS
247Depressed Level of ConsciousnessFAERS: 18
Canada Vigilance: 7
Canada Vigilance
US FAERS
248DisorientationFAERS: 18US FAERS
249Drug effect incompleteFAERS: 18US FAERS
250DysphoniaFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
251Macular degenerationFAERS: 18US FAERS
252Muscle strainFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
253Post procedural complicationFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
254Blood alkaline phosphatase increasedFAERS: 17US FAERS
255Blood creatine phosphokinase increasedFAERS: 17US FAERS
256ColitisFAERS: 17US FAERS
257Depressed moodFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
258Drug ineffective for unapproved indicationFAERS: 17US FAERS
259GlaucomaFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
260HerniaFAERS: 17US FAERS
261HysterectomyFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
262Intracranial AneurysmFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
263ParaplegiaFAERS: 17OFFSIDES
US FAERS
264PhlebitisFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
265Post procedural infectionFAERS: 17US FAERS
266Prescribed overdoseFAERS: 17US FAERS
267Product prescribing errorFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
268Urinary IncontinenceFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
269AscitesFAERS: 16US FAERS
270Back disorderFAERS: 16US FAERS
271Blood iron decreasedFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
272DeafnessFAERS: 16US FAERS
273Pancreatic carcinomaFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
274RhabdomyolysisFAERS: 16US FAERS
275Rheumatoid ArthritisFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
276StressFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
277Vascular ruptureFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
278Wound ComplicationFAERS: 16US FAERS
279ArteriosclerosisFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
280AsthmaFAERS: 15US FAERS
281Bladder NeoplasmFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
282Blood pressure fluctuationFAERS: 15US FAERS
283Brain ContusionFAERS: 15US FAERS
284Brain DeathFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
285Dental cariesFAERS: 15US FAERS
286GastroenteritisFAERS: 15US FAERS
287HypersomniaFAERS: 15US FAERS
288Intestinal PerforationFAERS: 15US FAERS
289BradycardiaFAERS: 14US FAERS
290Dieulafoy's vascular malformationFAERS: 14US FAERS
291Drug level increasedFAERS: 14US FAERS
292Erectile dysfunctionFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
293Intestinal ObstructionFAERS: 14US FAERS
294StomatitisFAERS: 14US FAERS
295Therapeutic product ineffectiveFAERS: 14US FAERS
296Venous occlusionFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
297Wound InfectionFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
298skin abrasionFAERS: 14US FAERS
299AbscessFAERS: 13US FAERS
300Activities of daily living impairedFAERS: 13US FAERS
301Ankle FractureFAERS: 13US FAERS
302AppendicitisFAERS: 13US FAERS
303Blood cholesterol increasedFAERS: 13US FAERS
304Blood creatinine abnormalFAERS: 13US FAERS
305Bone painFAERS: 13US FAERS
306Coagulation test abnormalFAERS: 13US FAERS
307DeliriumFAERS: 13US FAERS
308DisabilityFAERS: 13US FAERS
309Expired product administeredFAERS: 13US FAERS
310Iron deficiencyFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
311Lipase increasedFAERS: 13
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
312Poor quality drug administeredFAERS: 13US FAERS
313Post procedural pulmonary embolismFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
314Postoperative thrombosisFAERS: 13US FAERS
315Pulmonary InfarctionFAERS: 13US FAERS
316Retinal Vein OcclusionFAERS: 13US FAERS
317Ruptured cerebral aneurysmFAERS: 13US FAERS
318Accidental exposure to product by childFAERS: 12US FAERS
319Carotid Artery ThrombosisFAERS: 12US FAERS
320ChokingFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
321CholecystitisFAERS: 12US FAERS
322CholelithiasisFAERS: 12US FAERS
323Coagulation factor X level increasedFAERS: 12OFFSIDES
US FAERS
324DermatitisFAERS: 12SIDER
US FAERS
325Drug diversionFAERS: 12US FAERS
326Gastrointestinal angiodysplasiaFAERS: 12US FAERS
327Gastrointestinal carcinomaFAERS: 12US FAERS
328Head discomfortFAERS: 12US FAERS
329Metabolic acidosisFAERS: 12US FAERS
330Metastatic NeoplasmFAERS: 12US FAERS
331Muscle tightnessFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
332Peripheral artery occlusionFAERS: 12US FAERS
333Retinal vascular thrombosisFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
334Rotator cuff syndromeFAERS: 12US FAERS
335VIIth nerve paralysisFAERS: 12US FAERS
336Accidental exposure to productFAERS: 11US FAERS
337Altered state of consciousnessFAERS: 11US FAERS
338BedriddenFAERS: 11US FAERS
339ErysipelasFAERS: 11US FAERS
340ExsanguinationFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
341FlushingFAERS: 11US FAERS
342Gait inabilityFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
343HepatotoxicityFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
344Incorrect product storageFAERS: 11US FAERS
345MonoplegiaFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
346Post procedural strokeFAERS: 11US FAERS
347Product shape issueFAERS: 11US FAERS
348RestlessnessFAERS: 11US FAERS
349SciaticaFAERS: 11US FAERS
350Splenic InfarctionFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
351ApathyFAERS: 10US FAERS
352AphagiaFAERS: 10US FAERS
353Apparent deathFAERS: 10US FAERS
354Blood sodium decreasedFAERS: 10US FAERS
355Blood urea increasedFAERS: 10SIDER
US FAERS
356Cataract operationFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
357Cerebral ventricular ruptureFAERS: 10US FAERS
358DiplegiaFAERS: 10US FAERS
359Epigastric discomfortFAERS: 10US FAERS
360FractureFAERS: 10US FAERS
361General physical condition abnormalFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
362HypoxiaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
363Large intestine perforationFAERS: 10US FAERS
364LymphomaFAERS: 10US FAERS
365MYELODYSPLASTIC SYNDROMEFAERS: 10US FAERS
366MonoparesisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
367Multiple allergiesFAERS: 10US FAERS
368Nonspecific reactionFAERS: 10US FAERS
369Peptic UlcerFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
370Peripheral arterial occlusive diseaseFAERS: 10US FAERS
371Productive CoughFAERS: 10US FAERS
372Retinal Artery OcclusionFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
373SeromaFAERS: 10US FAERS
374Tooth InfectionFAERS: 10US FAERS
375Troponin increasedFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
376Uterine CancerFAERS: 10US FAERS
377WheezingFAERS: 10US FAERS
378Abnormal weight gainFAERS: 9US FAERS
379Anticoagulation drug level above therapeuticFAERS: 9US FAERS
380Blood creatine increasedFAERS: 9US FAERS
381Device related infectionFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
382Drug resistanceFAERS: 9US FAERS
383EczemaFAERS: 9US FAERS
384Emotional disorderFAERS: 9US FAERS
385Emotional distressFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
386Facial paralysisFAERS: 9
Canada Vigilance: 3
Canada Vigilance
US FAERS
387Gastrointestinal PainFAERS: 9
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
388Hepatic EncephalopathyFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
389IleusFAERS: 9US FAERS
390IncontinenceFAERS: 9US FAERS
391Irritable Bowel SyndromeFAERS: 9US FAERS
392Joint stiffnessFAERS: 9US FAERS
393LeukocytosisFAERS: 9US FAERS
394Multiple SclerosisFAERS: 9US FAERS
395Musculoskeletal discomfortFAERS: 9US FAERS
396NecrosisFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
397NoduleFAERS: 9US FAERS
398Polymyalgia RheumaticaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
399Portal Vein ThrombosisFAERS: 9US FAERS
400Procedural complicationFAERS: 9US FAERS
401Prothrombin level decreasedFAERS: 9US FAERS
402PyelonephritisFAERS: 9US FAERS
403Right ventricular failureFAERS: 9US FAERS
404Skin reactionFAERS: 9US FAERS
405Anti factor X antibody positiveFAERS: 8US FAERS
406Basilar artery thrombosisFAERS: 8US FAERS
407BiopsyFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
408Cardiac assistance device userFAERS: 8US FAERS
409CardiomegalyFAERS: 8US FAERS
410Depression suicidalFAERS: 8US FAERS
411DuodenitisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
412Ejection Fraction DecreasedFAERS: 8US FAERS
413Gastrointestinal erosionFAERS: 8US FAERS
414Impaired driving abilityFAERS: 8US FAERS
415Implantable defibrillator insertionFAERS: 8US FAERS
416Intracranial massFAERS: 8US FAERS
417Meniscus injuryFAERS: 8US FAERS
418NeuralgiaFAERS: 8US FAERS
419OsteomyelitisFAERS: 8US FAERS
420PolyarthritisFAERS: 8US FAERS
421Pulmonary FibrosisFAERS: 8US FAERS
422Respiratory arrestFAERS: 8US FAERS
423Restless Legs SyndromeFAERS: 8US FAERS
424RetchingFAERS: 8US FAERS
425ScabFAERS: 8US FAERS
426Spinal column stenosisFAERS: 8US FAERS
427Spinal fusion surgeryFAERS: 8US FAERS
428SunburnFAERS: 8US FAERS
429Tooth LossFAERS: 8US FAERS
430AgeusiaFAERS: 7US FAERS
431AgranulocytosisFAERS: 7SIDER
US FAERS
432Amylase increasedFAERS: 7SIDER
US FAERS
433AtaxiaFAERS: 7US FAERS
434Atrioventricular BlockFAERS: 7US FAERS
435Bleeding time abnormalFAERS: 7US FAERS
436Blood creatinine decreasedFAERS: 7US FAERS
437Blood glucose fluctuationFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
438Blood lactate dehydrogenase increasedFAERS: 7
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
439BradyphreniaFAERS: 7US FAERS
440BronchiectasisFAERS: 7SIDER
US FAERS
441BursitisFAERS: 7US FAERS
442Cerebral Amyloid AngiopathyFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
443ChemotherapyFAERS: 7US FAERS
444CholestasisFAERS: 7SIDER
US FAERS
445Disease ProgressionFAERS: 7US FAERS
446Drug level below therapeuticFAERS: 7US FAERS
447Ear discomfortFAERS: 7US FAERS
448EndocarditisFAERS: 7US FAERS
449EosinophiliaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
450EructationFAERS: 7US FAERS
451Erythema MultiformeFAERS: 7SIDER
US FAERS
452Extremity necrosisFAERS: 7US FAERS
453Eye irritationFAERS: 7US FAERS
454FibromyalgiaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
455Gastrointestinal motility disorderFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
456Gastrointestinal ulcerFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
457HydronephrosisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
458Joint Range of Motion DecreasedFAERS: 7
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
459Mouth swellingFAERS: 7US FAERS
460Musculoskeletal chest painFAERS: 7US FAERS
461Neurological decompensationFAERS: 7US FAERS
462ObesityFAERS: 7US FAERS
463OsteoporosisFAERS: 7US FAERS
464Pain of skinFAERS: 7US FAERS
465ParanoiaFAERS: 7US FAERS
466Peripheral venous diseaseFAERS: 7US FAERS
467PeritonitisFAERS: 7US FAERS
468Platelet count abnormalFAERS: 7US FAERS
469Postoperative wound complicationFAERS: 7US FAERS
470Product label confusionFAERS: 7US FAERS
471ProteinuriaFAERS: 7US FAERS
472Pulmonary artery thrombosisFAERS: 7US FAERS
473Quality of life decreasedFAERS: 7
Canada Vigilance: 3
Canada Vigilance
US FAERS
474Renal embolismFAERS: 7US FAERS
475Skin irritationFAERS: 7US FAERS
476Sudden Cardiac DeathFAERS: 7US FAERS
477Throat irritationFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
478Thrombotic cerebral infarctionFAERS: 7US FAERS
479Vascular occlusionFAERS: 7US FAERS
480Vascular stent thrombosisFAERS: 7US FAERS
481Ventricular FibrillationFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
482Vitreous DetachmentFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
483Wound dehiscenceFAERS: 7US FAERS
484AngerFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
485AnhedoniaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
486AnuriaFAERS: 6US FAERS
487Aphthous StomatitisFAERS: 6US FAERS
488AtelectasisFAERS: 6US FAERS
489Axillary vein thrombosisFAERS: 6US FAERS
490Bladder tamponadeFAERS: 6US FAERS
491Blood glucose decreasedFAERS: 6US FAERS
492Blood triglycerides increasedFAERS: 6US FAERS
493Cardiac FlutterFAERS: 6US FAERS
494Cardiac valve replacement complicationFAERS: 6US FAERS
495Carpal Tunnel SyndromeFAERS: 6US FAERS
496Central nervous system lesionFAERS: 6US FAERS
497Clostridium difficile infectionFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
498Coagulation factor X level decreasedFAERS: 6US FAERS
499Contraindicated drug administeredFAERS: 6US FAERS
500Creatinine renal clearance increasedFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
501CyanosisFAERS: 6US FAERS
502Drug administered to patient of inappropriate ageFAERS: 6US FAERS
503Guillain-Barre SyndromeFAERS: 6US FAERS
504Heparin-induced thrombocytopeniaFAERS: 6US FAERS
505Hepatitis CFAERS: 6US FAERS
506Hypertensive heart diseaseFAERS: 6US FAERS
507HyperthyroidismFAERS: 6US FAERS
508HypophagiaFAERS: 6US FAERS
509HypothyroidismFAERS: 6US FAERS
510Inappropriate PrescribingFAERS: 6US FAERS
511Intercepted medication errorFAERS: 6US FAERS
512Intestinal infarctionFAERS: 6US FAERS
513Leukocytoclastic vasculitisFAERS: 6US FAERS
514Limb operationFAERS: 6US FAERS
515Lower respiratory tract infectionFAERS: 6US FAERS
516LymphadenopathyFAERS: 6US FAERS
517Medication residue presentFAERS: 6US FAERS
518MeningitisFAERS: 6US FAERS
519Middle insomniaFAERS: 6US FAERS
520MultimorbidityFAERS: 6US FAERS
521Muscle FatigueFAERS: 6US FAERS
522Nerve injuryFAERS: 6US FAERS
523Night sweatsFAERS: 6US FAERS
524Ocular discomfortFAERS: 6US FAERS
525Perforated ulcerFAERS: 6US FAERS
526Personality ChangeFAERS: 6US FAERS
527PolyneuropathyFAERS: 6US FAERS
528Poor peripheral circulationFAERS: 6US FAERS
529Post procedural dischargeFAERS: 6OFFSIDES
US FAERS
530Post procedural swellingFAERS: 6US FAERS
531Product dispensing errorFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
532Product use complaintFAERS: 6US FAERS
533Respiratory tract congestionFAERS: 6US FAERS
534Septic embolusFAERS: 6US FAERS
535SplenectomyFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
536Status EpilepticusFAERS: 6US FAERS
537Systemic Inflammatory Response SyndromeFAERS: 6US FAERS
538Therapy changeFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
539Urine output increasedFAERS: 6US FAERS
540Vena cava filter insertionFAERS: 6US FAERS
541Viral upper respiratory tract infectionFAERS: 6US FAERS
542Abdominal symptomFAERS: 5US FAERS
543Activated partial thromboplastin time abnormalFAERS: 5US FAERS
544Amaurosis FugaxFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
545Aortic RuptureFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
546AsphyxiaFAERS: 5US FAERS
547Blood potassium decreasedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
548BronchospasmFAERS: 5US FAERS
549Catheter placementFAERS: 5US FAERS
550Coronary artery embolismFAERS: 5US FAERS
551Device dislocationFAERS: 5US FAERS
552Disease recurrenceFAERS: 5US FAERS
553Facial ParesisFAERS: 5US FAERS
554Factor V Leiden mutationFAERS: 5US FAERS
555Fluid overloadFAERS: 5US FAERS
556FrustrationFAERS: 5US FAERS
557Full blood count abnormalFAERS: 5US FAERS
558GangreneFAERS: 5US FAERS
559Gastrointestinal arteriovenous malformationFAERS: 5US FAERS
560HepatomegalyFAERS: 5US FAERS
561HyperchlorhydriaFAERS: 5US FAERS
562Hypertensive emergencyFAERS: 5US FAERS
563IncoherentFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
564Intermittent ClaudicationFAERS: 5US FAERS
565LaryngitisFAERS: 5US FAERS
566Loss of personal independence in daily activitiesFAERS: 5US FAERS
567Low birth weight babyFAERS: 5US FAERS
568Malignant neoplasm progressionFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
569MetamorphopsiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
570MetastasisFAERS: 5US FAERS
571Migraine with AuraFAERS: 5US FAERS
572Myasthenia GravisFAERS: 5US FAERS
573OnychoclasisFAERS: 5US FAERS
574Oral infectionFAERS: 5US FAERS
575PoisoningFAERS: 5US FAERS
576Product availability issueFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
577Product coating issueFAERS: 5US FAERS
578Product substitution issueFAERS: 5US FAERS
579Product tamperingFAERS: 5US FAERS
580Prothrombin time abnormalFAERS: 5US FAERS
581QuadriplegiaFAERS: 5US FAERS
582Renal ColicFAERS: 5US FAERS
583Renal cystFAERS: 5US FAERS
584Sinus TachycardiaFAERS: 5US FAERS
585Sinus headacheFAERS: 5US FAERS
586Sjogren's SyndromeFAERS: 5US FAERS
587SplenomegalyFAERS: 5US FAERS
588Tension HeadacheFAERS: 5US FAERS
589Thalamic infarctionFAERS: 5US FAERS
590ThirstFAERS: 5US FAERS
591TuberculosisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
592Upper-airway cough syndromeFAERS: 5US FAERS
593Urinary tract obstructionFAERS: 5US FAERS
594Vascular pseudoaneurysm rupturedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
595Ventricle ruptureFAERS: 5US FAERS
596Walking aid userFAERS: 5US FAERS
597muscle injuryFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
598Abnormal clotting factorFAERS: 4US FAERS
599AcidosisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
600Activated partial thromboplastin time shortenedFAERS: 4US FAERS
601Acute left ventricular failureFAERS: 4US FAERS
602AdenocarcinomaFAERS: 4US FAERS
603Anaphylactic shockFAERS: 4SIDER
US FAERS
604Anastomotic ulcerFAERS: 4US FAERS
605AngiodysplasiaFAERS: 4US FAERS
606Anticoagulation drug level below therapeuticFAERS: 4US FAERS
607Anticoagulation drug level increasedFAERS: 4US FAERS
608Antiphospholipid AntibodiesFAERS: 4US FAERS
609Arthropod biteFAERS: 4US FAERS
610Bacterial test positiveFAERS: 4US FAERS
611Blood albumin decreasedFAERS: 4US FAERS
612Blood potassium increasedFAERS: 4US FAERS
613Cerebral ArteriosclerosisFAERS: 4US FAERS
614Cerebral disorderFAERS: 4US FAERS
615Cerebral microhaemorrhageFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
616Cerebral vascular occlusionFAERS: 4US FAERS
617Cervix carcinomaFAERS: 4US FAERS
618Choking sensationFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
619Cold sweatFAERS: 4US FAERS
620Complication associated with deviceFAERS: 4US FAERS
621Contraindicated drug prescribedFAERS: 4US FAERS
622CryingFAERS: 4US FAERS
623Device FailureFAERS: 4US FAERS
624Device occlusionFAERS: 4US FAERS
625Diabetes mellitus inadequate controlFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
626Drug level decreasedFAERS: 4US FAERS
627Drug withdrawal syndromeFAERS: 4US FAERS
628Economic problemFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
629Eosinophilic PneumoniaFAERS: 4US FAERS
630False positive investigation resultFAERS: 4US FAERS
631Feeling of body temperature changeFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
632Foreign body sensation in eyesFAERS: 4US FAERS
633FormicationFAERS: 4US FAERS
634Gastroduodenitis haemorrhagicFAERS: 4US FAERS
635Gastrointestinal angiectasiaFAERS: 4US FAERS
636Gastrointestinal perforationFAERS: 4US FAERS
637Incision site painFAERS: 4US FAERS
638Incorrect product administration durationFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
639IndurationFAERS: 4US FAERS
640Initial insomniaFAERS: 4US FAERS
641Intentional drug misuseFAERS: 4US FAERS
642Large intestinal polypectomyFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
643Loose toothFAERS: 4US FAERS
644Low density lipoprotein increasedFAERS: 4US FAERS
645Mechanical ventilationFAERS: 4US FAERS
646Medical device complicationFAERS: 4US FAERS
647Mitral Valve StenosisFAERS: 4US FAERS
648Mood swingsFAERS: 4US FAERS
649ObstructionFAERS: 4US FAERS
650Ocular icterusFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
651ParesisFAERS: 4US FAERS
652Penile size reducedFAERS: 4US FAERS
653Percutaneous Coronary InterventionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
654PneumonitisFAERS: 4US FAERS
655Poor quality sleepFAERS: 4US FAERS
656Portal hypertensive gastropathyFAERS: 4US FAERS
657Procedural site reactionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
658Product administration errorFAERS: 4
Canada Vigilance: 5
Canada Vigilance
US FAERS
659Product counterfeitFAERS: 4US FAERS
660Protein S DeficiencyFAERS: 4US FAERS
661Protein urine presentFAERS: 4US FAERS
662Prothrombin level abnormalFAERS: 4US FAERS
663PsoriasisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
664QuadriparesisFAERS: 4US FAERS
665Renal tubular necrosisFAERS: 4US FAERS
666Renal vascular thrombosisFAERS: 4US FAERS
667Retinal artery embolismFAERS: 4US FAERS
668Rheumatic disorderFAERS: 4US FAERS
669RosaceaFAERS: 4US FAERS
670Skin lacerationFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
671SneezingFAERS: 4US FAERS
672SoporFAERS: 4US FAERS
673Squamous cell carcinomaFAERS: 4US FAERS
674StenosisFAERS: 4US FAERS
675Suspected product contaminationFAERS: 4US FAERS
676TachyarrhythmiaFAERS: 4US FAERS
677Temporal ArteritisFAERS: 4US FAERS
678Thrombocytopenic purpuraFAERS: 4US FAERS
679TrichorrhexisFAERS: 4US FAERS
680Trousseau's syndromeFAERS: 4US FAERS
681Vitamin D DeficiencyFAERS: 4US FAERS
682Wheelchair userFAERS: 4US FAERS
683angiogramFAERS: 4US FAERS
684intensive careFAERS: 4US FAERS
685Abdominal AbscessFAERS: 3US FAERS
686Acute prerenal failureFAERS: 3US FAERS
687AkathisiaFAERS: 3US FAERS
688Alcohol poisoningFAERS: 3US FAERS
689Anal sphincter atonyFAERS: 3US FAERS
690AnosmiaFAERS: 3US FAERS
691Anti factor X activity increasedFAERS: 3US FAERS
692Anticoagulant therapyFAERS: 3US FAERS
693Anticoagulation drug level decreasedFAERS: 3US FAERS
694Antithrombin III decreasedFAERS: 3US FAERS
695AphoniaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
696Arterial InjuryFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
697Autonomic neuropathyFAERS: 3US FAERS
698Benign Prostatic HyperplasiaFAERS: 3US FAERS
699Bladder dysfunctionFAERS: 3US FAERS
700Blister ruptureFAERS: 3US FAERS
701Blood creatine phosphokinase MB increasedFAERS: 3US FAERS
702Blood fibrinogen increasedFAERS: 3OFFSIDES
US FAERS
703Blood glucose abnormalFAERS: 3US FAERS
704Blood homocysteine increasedFAERS: 3US FAERS
705Blood thyroid stimulating hormone decreasedFAERS: 3US FAERS
706Brain stem syndromeFAERS: 3US FAERS
707Breast discomfortFAERS: 3US FAERS
708Carcinoembryonic antigen increasedFAERS: 3US FAERS
709Cardiac perforationFAERS: 3US FAERS
710Cerebellar strokeFAERS: 3US FAERS
711CholangiocarcinomaFAERS: 3US FAERS
712Chronic respiratory failureFAERS: 3US FAERS
713Clostridium difficile colitisFAERS: 3US FAERS
714Coagulation factor VIII level increasedFAERS: 3US FAERS
715ColectomyFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
716Completed SuicideFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
717Congenital cerebral cystFAERS: 3US FAERS
718Corrective lens userFAERS: 3US FAERS
719CystFAERS: 3US FAERS
720Decreased immune responsivenessFAERS: 3US FAERS
721Device malfunctionFAERS: 3US FAERS
722Diffuse alopeciaFAERS: 3US FAERS
723DroolingFAERS: 3US FAERS
724Drug level above therapeuticFAERS: 3US FAERS
725Drug monitoring procedure incorrectly performedFAERS: 3US FAERS
726EnteritisFAERS: 3US FAERS
727Escherichia urinary tract infectionFAERS: 3US FAERS
728Exfoliative rashFAERS: 3US FAERS
729Facial PainFAERS: 3US FAERS
730Failure to ThriveFAERS: 3US FAERS
731FasciitisFAERS: 3US FAERS
732Feeling jitteryFAERS: 3US FAERS
733Food AllergyFAERS: 3US FAERS
734Full blood count decreasedFAERS: 3US FAERS
735Gallbladder painFAERS: 3US FAERS
736GastrectomyFAERS: 3US FAERS
737Gastric BypassFAERS: 3US FAERS
738Gastric mucosal lesionFAERS: 3US FAERS
739Gastrointestinal inflammationFAERS: 3US FAERS
740GastrostomyFAERS: 3US FAERS
741GingivitisFAERS: 3US FAERS
742Grip strength decreasedFAERS: 3US FAERS
743Helicobacter test positiveFAERS: 3US FAERS
744Hepatic InfarctionFAERS: 3US FAERS
745Hepatic necrosisFAERS: 3US FAERS
746Hypereosinophilic syndromeFAERS: 3US FAERS
747HyperventilationFAERS: 3US FAERS
748Hypocoagulable stateFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
749HypoventilationFAERS: 3US FAERS
750Infectious MononucleosisFAERS: 3US FAERS
751Injury associated with deviceFAERS: 3US FAERS
752Intentional dose omissionFAERS: 3US FAERS
753Intestinal resectionFAERS: 3US FAERS
754Lateral Medullary SyndromeFAERS: 3US FAERS
755Ligament ruptureFAERS: 3US FAERS
756Limb massFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
757Lyme DiseaseFAERS: 3US FAERS
758MeningiomaFAERS: 3US FAERS
759MeningorrhagiaFAERS: 3US FAERS
760MicroembolismFAERS: 3US FAERS
761Multiple sclerosis relapseFAERS: 3US FAERS
762NephrectomyFAERS: 3US FAERS
763No adverse eventFAERS: 3US FAERS
764NocturiaFAERS: 3US FAERS
765Oral painFAERS: 3US FAERS
766OverweightFAERS: 3US FAERS
767ParaparesisFAERS: 3OFFSIDES
US FAERS
768Pelvic massFAERS: 3OFFSIDES
US FAERS
769PeriarthritisFAERS: 3US FAERS
770PharyngitisFAERS: 3US FAERS
771PleurisyFAERS: 3US FAERS
772Pleuritic painFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
773PolyuriaFAERS: 3US FAERS
774Poor dental conditionFAERS: 3US FAERS
775Poor quality product administeredFAERS: 3US FAERS
776Post procedural sepsisFAERS: 3US FAERS
777Post-Traumatic Stress DisorderFAERS: 3US FAERS
778Pre-EclampsiaFAERS: 3US FAERS
779Product communication issueFAERS: 3US FAERS
780Product contaminationFAERS: 3US FAERS
781Product storage errorFAERS: 3US FAERS
782Product supply issueFAERS: 3US FAERS
783Prothrombin time ratio decreasedFAERS: 3US FAERS
784Pulmonary congestionFAERS: 3US FAERS
785Pulmonary microemboliFAERS: 3US FAERS
786Pulmonary painFAERS: 3US FAERS
787Pulmonary vein occlusionFAERS: 3US FAERS
788Radiation proctitisFAERS: 3US FAERS
789Renal Cell CarcinomaFAERS: 3US FAERS
790Retinal vascular occlusionFAERS: 3US FAERS
791Russell's viper venom time abnormalFAERS: 3US FAERS
792Skeletal injuryFAERS: 3US FAERS
793Skin IndurationFAERS: 3US FAERS
794Skin WrinklingFAERS: 3US FAERS
795Skin tightnessFAERS: 3US FAERS
796Splenic thrombosisFAERS: 3US FAERS
797Subcutaneous AbscessFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
798Sudden onset of sleepFAERS: 3US FAERS
799TonsillitisFAERS: 3US FAERS
800Toxic Epidermal NecrolysisFAERS: 3US FAERS
801Traumatic fractureFAERS: 3US FAERS
802Urinary hesitationFAERS: 3US FAERS
803Vaginal DischargeFAERS: 3US FAERS
804Vascular graft thrombosisFAERS: 3US FAERS
805Vascular purpuraFAERS: 3US FAERS
806Vasculitic rashFAERS: 3US FAERS
807Ventricular hypokinesiaFAERS: 3US FAERS
808Wound infection staphylococcalFAERS: 3OFFSIDES
US FAERS
809effusionFAERS: 3OFFSIDES
US FAERS
810prostatitisFAERS: 3US FAERS
811Abdominal Compartment SyndromeFAERS: 2US FAERS
812AcarodermatitisFAERS: 2US FAERS
813Acute right ventricular failureFAERS: 2US FAERS
814Alcohol interactionFAERS: 2US FAERS
815AmputationFAERS: 2US FAERS
816AmyloidosisFAERS: 2US FAERS
817Amyotrophic Lateral SclerosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
818Anal FissureFAERS: 2US FAERS
819Anal FistulaFAERS: 2US FAERS
820AngioplastyFAERS: 2US FAERS
821Angle Closure GlaucomaFAERS: 2US FAERS
822Animal scratchFAERS: 2US FAERS
823Anti factor V antibody positiveFAERS: 2US FAERS
824Antibody test positiveFAERS: 2US FAERS
825Aortic aneurysm repairFAERS: 2US FAERS
826Aortic surgeryFAERS: 2US FAERS
827Apallic syndromeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
828Apparent life threatening eventFAERS: 2US FAERS
829ArthroscopyFAERS: 2US FAERS
830Atypical pneumoniaFAERS: 2US FAERS
831Autoimmune hepatitisFAERS: 2US FAERS
832Bacterial VaginosisFAERS: 2US FAERS
833Basal cell carcinomaFAERS: 2US FAERS
834Basal ganglia strokeFAERS: 2US FAERS
835Basilar artery occlusionFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
836Biliary cancer metastaticFAERS: 2US FAERS
837Bipolar DisorderFAERS: 2US FAERS
838Bladder cystFAERS: 2US FAERS
839Bladder discomfortFAERS: 2US FAERS
840Bladder spasmFAERS: 2US FAERS
841Blighted ovumFAERS: 2US FAERS
842Blood bilirubin abnormalFAERS: 2US FAERS
843Blood fibrinogen decreasedFAERS: 2US FAERS
844Blood pressure inadequately controlledFAERS: 2US FAERS
845Blood urea abnormalFAERS: 2US FAERS
846Bone density decreasedFAERS: 2US FAERS
847BronchoscopyFAERS: 2US FAERS
848CHA2DS2-VASc annual stroke risk highFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
849CalcinosisFAERS: 2US FAERS
850Capillary FragilityFAERS: 2US FAERS
851Cardiac DeathFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
852Cardiac HypertrophyFAERS: 2US FAERS
853Cardiac stress test abnormalFAERS: 2US FAERS
854Cardiac valve vegetationFAERS: 2US FAERS
855Catheter site dischargeFAERS: 2US FAERS
856Cerebral atrophyFAERS: 2US FAERS
857Cerebral ventricle collapseFAERS: 2US FAERS
858Cerebrovascular InsufficiencyFAERS: 2US FAERS
859Chemical peritonitisFAERS: 2US FAERS
860ChoreaFAERS: 2US FAERS
861Circumstance or information capable of leading to medication errorFAERS: 2US FAERS
862Coagulation factor IX level decreasedFAERS: 2US FAERS
863Coagulation factor V level decreasedFAERS: 2US FAERS
864Coagulation factor VIII level decreasedFAERS: 2US FAERS
865Coagulation factor X level abnormalFAERS: 2US FAERS
866Coagulation factor XI level increasedFAERS: 2US FAERS
867CoccidioidomycosisFAERS: 2US FAERS
868Coital bleedingFAERS: 2US FAERS
869Coma scale abnormalFAERS: 2US FAERS
870Complement factor C3 decreasedFAERS: 2US FAERS
871Complication of device removalFAERS: 2US FAERS
872ConjunctivitisFAERS: 2US FAERS
873Counterfeit drug administeredFAERS: 2US FAERS
874Deafness NeurosensoryFAERS: 2US FAERS
875DebridementFAERS: 2US FAERS
876Dengue FeverFAERS: 2US FAERS
877Dental Restoration FailureFAERS: 2US FAERS
878Dental prosthesis userFAERS: 2US FAERS
879Device breakageFAERS: 2US FAERS
880Diabetic KetoacidosisFAERS: 2US FAERS
881Disease complicationFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
882Distributive shockFAERS: 2US FAERS
883Dose calculation errorFAERS: 2US FAERS
884Drug abuseFAERS: 2US FAERS
885Drug effect delayedFAERS: 2US FAERS
886Drug screen false positiveFAERS: 2US FAERS
887Duodenal ulcer perforationFAERS: 2US FAERS
888DysgraphiaFAERS: 2US FAERS
889DysphemiaFAERS: 2US FAERS
890Echocardiogram abnormalFAERS: 2US FAERS
891Electrocardiogram ST-T segment abnormalFAERS: 2US FAERS
892Electrocardiogram abnormalFAERS: 2US FAERS
893Electroconvulsive TherapyFAERS: 2US FAERS
894Electrolyte imbalanceFAERS: 2US FAERS
895EmpyemaFAERS: 2US FAERS
896Endodontic procedureFAERS: 2US FAERS
897Endoscopy upper gastrointestinal tract abnormalFAERS: 2US FAERS
898Eosinophilic FasciitisFAERS: 2US FAERS
899Erosive DuodenitisFAERS: 2US FAERS
900Euphoric moodFAERS: 2US FAERS
901Exposure to unspecified agentFAERS: 2US FAERS
902Factor V deficiencyFAERS: 2US FAERS
903FasciotomyFAERS: 2US FAERS
904Fear of fallingFAERS: 2US FAERS
905Feeding tube complicationFAERS: 2US FAERS
906FolliculitisFAERS: 2US FAERS
907Gamma-glutamyltransferase abnormalFAERS: 2US FAERS
908Gas GangreneFAERS: 2US FAERS
909Gastric Antral Vascular EctasiaFAERS: 2US FAERS
910Gastric ulcer helicobacterFAERS: 2US FAERS
911Gastrointestinal obstructionFAERS: 2US FAERS
912Gastrointestinal sounds abnormalFAERS: 2US FAERS
913Gastrointestinal stoma complicationFAERS: 2US FAERS
914Gaze palsyFAERS: 2US FAERS
915General symptomFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
916Genital rashFAERS: 2US FAERS
917GlomerulonephritisFAERS: 2US FAERS
918HER-2 positive breast cancerFAERS: 2US FAERS
919Hepatic Vein ThrombosisFAERS: 2US FAERS
920Hepatic cancer metastaticFAERS: 2US FAERS
921Hepatic congestionFAERS: 2US FAERS
922Hepatic vascular thrombosisFAERS: 2US FAERS
923Hepatorenal SyndromeFAERS: 2US FAERS
924Herbal interactionFAERS: 2US FAERS
925HungerFAERS: 2US FAERS
926HyperplasiaFAERS: 2US FAERS
927ImmobileFAERS: 2US FAERS
928ImmunosuppressionFAERS: 2US FAERS
929Impaired work abilityFAERS: 2US FAERS
930ImpatienceFAERS: 2US FAERS
931Incision site infectionFAERS: 2US FAERS
932Incorrect route of drug administrationFAERS: 2US FAERS
933Incubator therapyFAERS: 2US FAERS
934Infectious pleural effusionFAERS: 2US FAERS
935InfertilityFAERS: 2US FAERS
936Inflammatory marker increasedFAERS: 2US FAERS
937Infrequent bowel movementsFAERS: 2US FAERS
938Injection site bruisingFAERS: 2US FAERS
939Injection site thrombosisFAERS: 2US FAERS
940Intentional self-injuryFAERS: 2US FAERS
941Intercepted drug prescribing errorFAERS: 2US FAERS
942Internal injuryFAERS: 2US FAERS
943Intervertebral Disc DegenerationFAERS: 2US FAERS
944IridocyclitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
945Joint fluid drainageFAERS: 2US FAERS
946KetoacidosisFAERS: 2US FAERS
947Labile blood pressureFAERS: 2US FAERS
948Lactose IntoleranceFAERS: 2US FAERS
949LaparotomyFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
950LazinessFAERS: 2US FAERS
951LipomaFAERS: 2US FAERS
952MalabsorptionFAERS: 2US FAERS
953Malignant HypertensionFAERS: 2US FAERS
954Mediastinal massFAERS: 2US FAERS
955Medical device implantationFAERS: 2US FAERS
956Medical procedureFAERS: 2US FAERS
957Medication monitoring errorFAERS: 2US FAERS
958MegacolonFAERS: 2US FAERS
959Meniscus operationFAERS: 2US FAERS
960Mesenteric arterial occlusionFAERS: 2US FAERS
961MiliariaFAERS: 2US FAERS
962Muscle RigidityFAERS: 2US FAERS
963Muscle SpasticityFAERS: 2US FAERS
964Myocardial ruptureFAERS: 2US FAERS
965MyoclonusFAERS: 2US FAERS
966Myoglobin blood increasedFAERS: 2US FAERS
967Nasal PolypsFAERS: 2US FAERS
968NephrosclerosisFAERS: 2US FAERS
969Nephrotic SyndromeFAERS: 2US FAERS
970Neurone-specific enolase increasedFAERS: 2US FAERS
971Neutropenic sepsisFAERS: 2US FAERS
972Nipple painFAERS: 2US FAERS
973Non-cardiac chest painFAERS: 2US FAERS
974NystagmusFAERS: 2US FAERS
975Obstructive shockFAERS: 2US FAERS
976Oncologic complicationFAERS: 2US FAERS
977Open woundFAERS: 2US FAERS
978Optic nerve infarctionFAERS: 2US FAERS
979Oropharyngeal discomfortFAERS: 2US FAERS
980OsteorrhagiaFAERS: 2US FAERS
981Ovarian cancer stage IVFAERS: 2US FAERS
982Ovarian vein thrombosisFAERS: 2US FAERS
983Oxygen supplementationFAERS: 2US FAERS
984Palatal swellingFAERS: 2US FAERS
985Pancreatic NeoplasmFAERS: 2US FAERS
986Pancreatic PseudocystFAERS: 2US FAERS
987PancreaticoduodenectomyFAERS: 2US FAERS
988PanniculitisFAERS: 2US FAERS
989Paranasal sinus hypersecretionFAERS: 2US FAERS
990Patient dissatisfaction with treatmentFAERS: 2US FAERS
991Pelvic InfectionFAERS: 2US FAERS
992Pelvic PainFAERS: 2US FAERS
993Performance status decreasedFAERS: 2US FAERS
994Perinephric collectionFAERS: 2US FAERS
995Peripheral artery stenosisFAERS: 2US FAERS
996PertussisFAERS: 2US FAERS
997Pharyngeal polypFAERS: 2US FAERS
998PhlebosclerosisFAERS: 2US FAERS
999PhotophobiaFAERS: 2US FAERS
1000PneumoperitoneumFAERS: 2US FAERS
1001Postoperative abscessFAERS: 2US FAERS
1002Postoperative respiratory failureFAERS: 2US FAERS
1003Potentiating drug interactionFAERS: 2US FAERS
1004Pre-existing condition improvedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1005PregnancyFAERS: 2US FAERS
1006Procedural hypotensionFAERS: 2US FAERS
1007ProctitisFAERS: 2US FAERS
1008Product administered to patient of inappropriate ageFAERS: 2US FAERS
1009Product container issueFAERS: 2US FAERS
1010Product container seal issueFAERS: 2US FAERS
1011Product dosage form confusionFAERS: 2US FAERS
1012Product expiration date issueFAERS: 2US FAERS
1013Product used for unknown indicationFAERS: 2US FAERS
1014ProsopagnosiaFAERS: 2US FAERS
1015ProstatectomyFAERS: 2US FAERS
1016Prostatic varicesFAERS: 2US FAERS
1017Protein C DeficiencyFAERS: 2US FAERS
1018Protein total abnormalFAERS: 2US FAERS
1019PrurigoFAERS: 2US FAERS
1020PseudolymphomaFAERS: 2US FAERS
1021Pulmonary EosinophiliaFAERS: 2US FAERS
1022Pulmonary sepsisFAERS: 2US FAERS
1023Rebound effectFAERS: 2US FAERS
1024Rectal fissureFAERS: 2US FAERS
1025Rectal polypFAERS: 2US FAERS
1026Rectal tenesmusFAERS: 2US FAERS
1027Refractory cytopenia with unilineage dysplasiaFAERS: 2US FAERS
1028Rehabilitation therapyFAERS: 2US FAERS
1029Renal artery occlusionFAERS: 2US FAERS
1030Renal massFAERS: 2US FAERS
1031Respiratory DepressionFAERS: 2US FAERS
1032RhinalgiaFAERS: 2US FAERS
1033RhinitisFAERS: 2US FAERS
1034SarcoidosisFAERS: 2US FAERS
1035Secretion dischargeFAERS: 2OFFSIDES
US FAERS
1036Sensation of blood flowFAERS: 2US FAERS
1037Sense of oppressionFAERS: 2US FAERS
1038Skin neoplasm bleedingFAERS: 2US FAERS
1039Soft tissue swellingFAERS: 2US FAERS
1040Spinal column injuryFAERS: 2US FAERS
1041Splenic embolismFAERS: 2US FAERS
1042SpondylitisFAERS: 2US FAERS
1043Stasis dermatitisFAERS: 2US FAERS
1044Stent-graft endoleakFAERS: 2US FAERS
1045Stomach scan abnormalFAERS: 2US FAERS
1046StuporFAERS: 2US FAERS
1047Subacute hepatic failureFAERS: 2US FAERS
1048SuperinfectionFAERS: 2US FAERS
1049Supraventricular tachycardiaFAERS: 2US FAERS
1050Synovial CystFAERS: 2US FAERS
1051Thermal burnFAERS: 2US FAERS
1052ThrombectomyFAERS: 2US FAERS
1053Tinea PedisFAERS: 2US FAERS
1054Tongue bitingFAERS: 2US FAERS
1055Transaminases abnormalFAERS: 2US FAERS
1056Transcription medication errorFAERS: 2US FAERS
1057Traumatic liver injuryFAERS: 2US FAERS
1058Trigeminal NeuralgiaFAERS: 2US FAERS
1059Ultrasound liver abnormalFAERS: 2US FAERS
1060Vaginal erosionFAERS: 2US FAERS
1061Vascular compressionFAERS: 2US FAERS
1062Vascular painFAERS: 2US FAERS
1063Vascular stent insertionFAERS: 2US FAERS
1064Venous InjuryFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1065Ventricular drainageFAERS: 2US FAERS
1066Vertebral Artery DissectionFAERS: 2US FAERS
1067Vertebral artery occlusionFAERS: 2US FAERS
1068Vitreous floatersFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
1069Waist circumference increasedFAERS: 2US FAERS
1070Wrong drug administeredFAERS: 2US FAERS
1071Wrong product administeredFAERS: 2US FAERS
1072furuncleFAERS: 2US FAERS
1073Abdominal InfectionFAERS: 1US FAERS
1074Abdominal massFAERS: 1US FAERS
1075Abdominal rigidityFAERS: 1US FAERS
1076Abdominal strangulated herniaFAERS: 1US FAERS
1077Abdominal tendernessFAERS: 1US FAERS
1078Abnormal withdrawal bleedingFAERS: 1US FAERS
1079Accidental deathFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1080Acinetobacter test positiveFAERS: 1US FAERS
1081Acoustic NeuromaFAERS: 1US FAERS
1082AcromegalyFAERS: 1US FAERS
1083Activated partial thromboplastin time normalFAERS: 1US FAERS
1084Activated partial thromboplastin time ratioFAERS: 1US FAERS
1085Acute sinusitisFAERS: 1US FAERS
1086AkinesiaFAERS: 1US FAERS
1087Albumin globulin ratio decreasedFAERS: 1US FAERS
1088Alcohol IntoleranceFAERS: 1US FAERS
1089Allergy to animalFAERS: 1US FAERS
1090Alopecia AreataFAERS: 1US FAERS
1091Alveolar lung diseaseFAERS: 1US FAERS
1092AlveolitisFAERS: 1US FAERS
1093AmaurosisFAERS: 1US FAERS
1094Anaphylactoid ReactionFAERS: 1US FAERS
1095Anembryonic gestationFAERS: 1US FAERS
1096Animal biteFAERS: 1US FAERS
1097Anti factor X activity decreasedFAERS: 1US FAERS
1098Anti-platelet antibody positiveFAERS: 1US FAERS
1099Antinuclear antibody increasedFAERS: 1US FAERS
1100Antithrombin III increasedFAERS: 1US FAERS
1101Aortic InjuryFAERS: 1US FAERS
1102Aortic Valve StenosisFAERS: 1US FAERS
1103Aortic bypassFAERS: 1US FAERS
1104Aortic embolusFAERS: 1US FAERS
1105Aortic perforationFAERS: 1US FAERS
1106Aortic valve calcificationFAERS: 1US FAERS
1107Arrhythmogenic Right Ventricular DysplasiaFAERS: 1US FAERS
1108Arterial bypass operationFAERS: 1US FAERS
1109Arteriovenous fistulaFAERS: 1US FAERS
1110ArteritisFAERS: 1US FAERS
1111ArthrogramFAERS: 1US FAERS
1112Arthropod stingFAERS: 1US FAERS
1113Artificial heart implantFAERS: 1US FAERS
1114Atrial tachycardiaFAERS: 1US FAERS
1115Autoimmune thyroid disorderFAERS: 1US FAERS
1116BabesiosisFAERS: 1US FAERS
1117BalanoposthitisFAERS: 1US FAERS
1118Bed restFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1119BelligerenceFAERS: 1US FAERS
1120Benign neoplasm of adrenal glandFAERS: 1US FAERS
1121Bile Duct StenosisFAERS: 1US FAERS
1122Biliary ColicFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1123Biliary cirrhosisFAERS: 1US FAERS
1124Biopsy brainFAERS: 1US FAERS
1125Bipolar I disorderFAERS: 1US FAERS
1126Bladder DiverticulumFAERS: 1US FAERS
1127Bladder painFAERS: 1US FAERS
1128Bladder prolapseFAERS: 1US FAERS
1129Bladder stenosisFAERS: 1US FAERS
1130Blood alcohol abnormalFAERS: 1US FAERS
1131Blood bicarbonate abnormalFAERS: 1US FAERS
1132Blood bilirubin unconjugated increasedFAERS: 1US FAERS
1133Blood cholesterol abnormalFAERS: 1US FAERS
1134Blood creatine decreasedFAERS: 1US FAERS
1135Blood erythropoietin decreasedFAERS: 1US FAERS
1136Blood folate decreasedFAERS: 1US FAERS
1137Blood heavy metal increasedFAERS: 1US FAERS
1138Blood immunoglobulin E increasedFAERS: 1US FAERS
1139Blood iron abnormalFAERS: 1US FAERS
1140Blood magnesium decreasedFAERS: 1US FAERS
1141Blood magnesium increasedFAERS: 1US FAERS
1142Blood osmolarity decreasedFAERS: 1US FAERS
1143Blood pH decreasedFAERS: 1US FAERS
1144Blood phosphorus decreasedFAERS: 1US FAERS
1145Blood phosphorus increasedFAERS: 1US FAERS
1146Blood pressure immeasurableFAERS: 1US FAERS
1147Blood sodium increasedFAERS: 1US FAERS
1148Blood testosterone decreasedFAERS: 1US FAERS
1149Blood thromboplastin increasedFAERS: 1US FAERS
1150Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
1151Blood urea nitrogen/creatinine ratio increasedFAERS: 1US FAERS
1152Blood uric acidFAERS: 1US FAERS
1153Blood urine absentFAERS: 1US FAERS
1154Blood viscosity decreasedFAERS: 1US FAERS
1155Blue Toe SyndromeFAERS: 1US FAERS
1156Bone abscessFAERS: 1US FAERS
1157Bone contusionFAERS: 1US FAERS
1158Bone density abnormalFAERS: 1US FAERS
1159Bone marrow toxicityFAERS: 1US FAERS
1160Bone scan abnormalFAERS: 1US FAERS
1161Bone swellingFAERS: 1US FAERS
1162Brain AbscessFAERS: 1US FAERS
1163Brain HypoxiaFAERS: 1US FAERS
1164Brain natriuretic peptide increasedFAERS: 1US FAERS
1165Brain scan abnormalFAERS: 1US FAERS
1166Brain stem microhaemorrhageFAERS: 1US FAERS
1167Brain stem thrombosisFAERS: 1US FAERS
1168Breast cancer recurrentFAERS: 1US FAERS
1169Breast necrosisFAERS: 1US FAERS
1170Breast tendernessFAERS: 1US FAERS
1171Bronchial ObstructionFAERS: 1US FAERS
1172Bronchial secretion retentionFAERS: 1US FAERS
1173BronchopneumoniaFAERS: 1US FAERS
1174BronchopneumopathyFAERS: 1US FAERS
1175CREST SyndromeFAERS: 1US FAERS
1176CachexiaFAERS: 1US FAERS
1177Cancer PainFAERS: 1US FAERS
1178Capillary Leak SyndromeFAERS: 1US FAERS
1179Carbon Monoxide PoisoningFAERS: 1US FAERS
1180Cardiac asthmaFAERS: 1US FAERS
1181Cardiac discomfortFAERS: 1US FAERS
1182Cardiac dysfunctionFAERS: 1US FAERS
1183Cardiac enzymes increasedFAERS: 1US FAERS
1184Cardiac infectionFAERS: 1US FAERS
1185Cardiac pseudoaneurysmFAERS: 1US FAERS
1186Cardiac valve abscessFAERS: 1US FAERS
1187Cardioactive drug level increasedFAERS: 1US FAERS
1188Cardiovascular evaluationFAERS: 1US FAERS
1189Cardiovascular insufficiencyFAERS: 1US FAERS
1190Carotid EndarterectomyFAERS: 1US FAERS
1191Catheter site erosionFAERS: 1US FAERS
1192Catheter site painFAERS: 1US FAERS
1193Cauda Equina SyndromeFAERS: 1US FAERS
1194Cell DeathFAERS: 1US FAERS
1195Cell marker increasedFAERS: 1US FAERS
1196Central Nervous System InfectionFAERS: 1US FAERS
1197Cerebellar artery occlusionFAERS: 1US FAERS
1198Cerebral PalsyFAERS: 1US FAERS
1199Cerebral vasoconstrictionFAERS: 1US FAERS
1200CholangitisFAERS: 1US FAERS
1201Cholecystitis infectiveFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1202CholecystostomyFAERS: 1US FAERS
1203Choroidal DetachmentFAERS: 1US FAERS
1204Chronic diseaseFAERS: 1US FAERS
1205Chronic gastritisFAERS: 1US FAERS
1206Clamping of blood vesselFAERS: 1US FAERS
1207ClaustrophobiaFAERS: 1US FAERS
1208Clostridium difficile sepsisFAERS: 1US FAERS
1209ClumsinessFAERS: 1US FAERS
1210Coagulation factor VII level decreasedFAERS: 1US FAERS
1211Coagulation factor increasedFAERS: 1US FAERS
1212Coagulation factor mutationFAERS: 1US FAERS
1213Coagulation time shortenedFAERS: 1US FAERS
1214Collateral CirculationFAERS: 1US FAERS
1215Colon adenomaFAERS: 1US FAERS
1216Colon cancer recurrentFAERS: 1US FAERS
1217Colostomy infectionFAERS: 1US FAERS
1218Complications of transplant surgeryFAERS: 1US FAERS
1219Compression fractureFAERS: 1US FAERS
1220Congenital heart valve disorderFAERS: 1US FAERS
1221Congenital hypercoagulationFAERS: 1US FAERS
1222Continuous Positive Airway PressureFAERS: 1US FAERS
1223Coombs test positiveFAERS: 1US FAERS
1224Cor pulmonaleFAERS: 1US FAERS
1225Coronary bypass thrombosisFAERS: 1US FAERS
1226Counterfeit product administeredFAERS: 1US FAERS
1227CraniectomyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1228CraniopharyngiomaFAERS: 1US FAERS
1229CraniotomyFAERS: 1US FAERS
1230Critical IllnessFAERS: 1US FAERS
1231Culture positiveFAERS: 1US FAERS
1232Cyst removalFAERS: 1US FAERS
1233CystoscopyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1234Dacryostenosis acquiredFAERS: 1US FAERS
1235Dandy-Walker SyndromeFAERS: 1US FAERS
1236Dark circles under eyesFAERS: 1US FAERS
1237Death of relativeFAERS: 1US FAERS
1238DeformityFAERS: 1US FAERS
1239Delusional disorder, unspecified typeFAERS: 1US FAERS
1240Dental PlaqueFAERS: 1US FAERS
1241Dependent ruborFAERS: 1US FAERS
1242Dermatitis acneiformFAERS: 1US FAERS
1243DermatomyositisFAERS: 1US FAERS
1244Device damageFAERS: 1US FAERS
1245Device looseningFAERS: 1US FAERS
1246Device pacing issueFAERS: 1US FAERS
1247Device use issueFAERS: 1US FAERS
1248Diabetes InsipidusFAERS: 1US FAERS
1249Diabetic RetinopathyFAERS: 1US FAERS
1250Diabetic metabolic decompensationFAERS: 1US FAERS
1251Diastolic dysfunctionFAERS: 1US FAERS
1252Diffuse alveolar damageFAERS: 1US FAERS
1253Disease susceptibilityFAERS: 1US FAERS
1254DissociationFAERS: 1US FAERS
1255Disturbance in sexual arousalFAERS: 1US FAERS
1256Diverticular perforationFAERS: 1US FAERS
1257Documented hypersensitivity to administered productFAERS: 1US FAERS
1258Drug administered at inappropriate siteFAERS: 1US FAERS
1259Drug clearance decreasedFAERS: 1US FAERS
1260Drug screen negativeFAERS: 1US FAERS
1261Drug specific antibody presentFAERS: 1US FAERS
1262Drug titration errorFAERS: 1US FAERS
1263Drug-disease interactionFAERS: 1US FAERS
1264Dry age-related macular degenerationFAERS: 1US FAERS
1265Duodenal perforationFAERS: 1US FAERS
1266DysbacteriosisFAERS: 1US FAERS
1267DyscalculiaFAERS: 1US FAERS
1268DysenteryFAERS: 1US FAERS
1269DysmorphismFAERS: 1US FAERS
1270Ear abrasionFAERS: 1US FAERS
1271Ear congestionFAERS: 1US FAERS
1272Ear tube insertionFAERS: 1US FAERS
1273Early satietyFAERS: 1US FAERS
1274EclampsiaFAERS: 1US FAERS
1275Ehrlichia test positiveFAERS: 1US FAERS
1276Elective procedureFAERS: 1US FAERS
1277Electrocardiogram QT interval abnormalFAERS: 1US FAERS
1278Electrocardiogram changeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1279Emergency CareFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1280EncephalitisFAERS: 1US FAERS
1281EndarterectomyFAERS: 1US FAERS
1282Endometrial HyperplasiaFAERS: 1US FAERS
1283Endometrial adenocarcinomaFAERS: 1US FAERS
1284Endometrial hypertrophyFAERS: 1US FAERS
1285EndometriosisFAERS: 1US FAERS
1286Endovenous ablationFAERS: 1US FAERS
1287EnterocolitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1288Enterovesical FistulaFAERS: 1US FAERS
1289EnuresisFAERS: 1US FAERS
1290Epidermal necrosisFAERS: 1US FAERS
1291EpidermolysisFAERS: 1US FAERS
1292Erythema NodosumFAERS: 1US FAERS
1293EscharFAERS: 1US FAERS
1294Escherichia sepsisFAERS: 1US FAERS
1295ExcoriationFAERS: 1US FAERS
1296Executive dysfunctionFAERS: 1US FAERS
1297ExophthalmosFAERS: 1US FAERS
1298Exposure during breast feedingFAERS: 1US FAERS
1299Exposure via body fluidFAERS: 1US FAERS
1300Extraocular Muscle ParesisFAERS: 1US FAERS
1301ExtravasationFAERS: 1US FAERS
1302Eye InfectionFAERS: 1US FAERS
1303Eye allergyFAERS: 1US FAERS
1304Eye laser surgeryFAERS: 1US FAERS
1305Eyelid Function DisorderFAERS: 1US FAERS
1306Factor II mutationFAERS: 1US FAERS
1307Febrile NeutropeniaFAERS: 1US FAERS
1308Femoral artery occlusionFAERS: 1US FAERS
1309Fixed drug eruptionFAERS: 1US FAERS
1310Focal Nodular HyperplasiaFAERS: 1US FAERS
1311Food PoisoningFAERS: 1US FAERS
1312Foreign body aspirationFAERS: 1US FAERS
1313Foreign body in respiratory tractFAERS: 1US FAERS
1314Frontotemporal dementiaFAERS: 1US FAERS
1315Gallbladder necrosisFAERS: 1US FAERS
1316Gastric DilatationFAERS: 1US FAERS
1317Gastric FistulaFAERS: 1US FAERS
1318Gastric occult blood positiveFAERS: 1US FAERS
1319GastroenterostomyFAERS: 1US FAERS
1320Gastrointestinal complication associated with deviceFAERS: 1US FAERS
1321Gastrointestinal dysplasiaFAERS: 1US FAERS
1322Gastrointestinal endoscopic therapyFAERS: 1US FAERS
1323Gastrointestinal infectionFAERS: 1US FAERS
1324Gastrointestinal procedural complicationFAERS: 1US FAERS
1325Gastrointestinal tract adenomaFAERS: 1US FAERS
1326Gene MutationFAERS: 1US FAERS
1327Gingival HyperplasiaFAERS: 1US FAERS
1328Gingival RecessionFAERS: 1US FAERS
1329Gingival erythemaFAERS: 1US FAERS
1330Glomerular Filtration RateFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
1331Graft thrombosisFAERS: 1US FAERS
1332Graft versus host disease in gastrointestinal tractFAERS: 1US FAERS
1333Granuloma AnnulareFAERS: 1US FAERS
1334Granulomatosis with polyangiitisFAERS: 1US FAERS
1335Granulomatous liver diseaseFAERS: 1US FAERS
1336Growing painsFAERS: 1US FAERS
1337Hallucinations, mixedFAERS: 1US FAERS
1338Head BangingFAERS: 1US FAERS
1339Heat illnessFAERS: 1US FAERS
1340Helicobacter duodenitisFAERS: 1US FAERS
1341HemiparaesthesiaFAERS: 1US FAERS
1342Hepatic InfectionFAERS: 1US FAERS
1343Hepatic artery occlusionFAERS: 1US FAERS
1344Hepatic cyst rupturedFAERS: 1US FAERS
1345Hepatitis AFAERS: 1US FAERS
1346Hepatitis EFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1347HidradenitisFAERS: 1US FAERS
1348Histamine intoleranceFAERS: 1US FAERS
1349HistoplasmosisFAERS: 1US FAERS
1350Homans' sign positiveFAERS: 1US FAERS
1351Hospice CareFAERS: 1US FAERS
1352Hydrocele operationFAERS: 1US FAERS
1353HyperacusisFAERS: 1US FAERS
1354HyperferritinaemiaFAERS: 1US FAERS
1355HyperkeratosisFAERS: 1US FAERS
1356HypermetabolismFAERS: 1US FAERS
1357HyperpyrexiaFAERS: 1US FAERS
1358Hypertensive cardiomyopathyFAERS: 1US FAERS
1359HypertransaminasaemiaFAERS: 1US FAERS
1360HypobarismFAERS: 1US FAERS
1361HypochondriasisFAERS: 1US FAERS
1362HypogeusiaFAERS: 1US FAERS
1363HyporeflexiaFAERS: 1US FAERS
1364Illness anxiety disorderFAERS: 1US FAERS
1365Impaired gastric emptyingFAERS: 1US FAERS
1366Implant site dischargeFAERS: 1US FAERS
1367Inappropriate release of product for distributionFAERS: 1US FAERS
1368Incarcerated herniaFAERS: 1US FAERS
1369Incision site complicationFAERS: 1US FAERS
1370Incision site erythemaFAERS: 1US FAERS
1371Incisional herniaFAERS: 1US FAERS
1372Incorrect route of product administrationFAERS: 1US FAERS
1373Increased upper airway secretionFAERS: 1US FAERS
1374Increased viscosity of nasal secretionFAERS: 1US FAERS
1375Infusion Site ExtravasationFAERS: 1US FAERS
1376Infusion site bruisingFAERS: 1US FAERS
1377Infusion site cellulitisFAERS: 1US FAERS
1378Infusion site infectionFAERS: 1US FAERS
1379Injection site cellulitisFAERS: 1US FAERS
1380Injection site erythemaFAERS: 1US FAERS
1381Insurance issueFAERS: 1US FAERS
1382Intercepted drug administration errorFAERS: 1US FAERS
1383Intercepted product prescribing errorFAERS: 1US FAERS
1384Interventional procedureFAERS: 1US FAERS
1385Intervertebral disc disorderFAERS: 1US FAERS
1386Intestinal gangreneFAERS: 1US FAERS
1387Intra-abdominal pressure increasedFAERS: 1US FAERS
1388IntussusceptionFAERS: 1US FAERS
1389Investigation noncomplianceFAERS: 1US FAERS
1390IritisFAERS: 1US FAERS
1391Joint destructionFAERS: 1US FAERS
1392Joint prosthesis userFAERS: 1US FAERS
1393Laboratory test interferenceFAERS: 1US FAERS
1394LabyrinthitisFAERS: 1US FAERS
1395Laser TherapyFAERS: 1US FAERS
1396Left Ventricular HypertrophyFAERS: 1US FAERS
1397Left atrial dilatationFAERS: 1US FAERS
1398Lemierre SyndromeFAERS: 1US FAERS
1399Ligament injuryFAERS: 1US FAERS
1400Limb crushing injuryFAERS: 1US FAERS
1401Limb fractureFAERS: 1US FAERS
1402Lip InfectionFAERS: 1US FAERS
1403Lip and/or oral cavity cancerFAERS: 1US FAERS
1404Lip neoplasm malignant stage unspecifiedFAERS: 1US FAERS
1405LithotripsyFAERS: 1US FAERS
1406LividityFAERS: 1US FAERS
1407Living in residential institutionFAERS: 1US FAERS
1408Low Cardiac Output SyndromeFAERS: 1US FAERS
1409Lower respiratory tract infection viralFAERS: 1US FAERS
1410Lung AbscessFAERS: 1US FAERS
1411Lung consolidationFAERS: 1US FAERS
1412Lung cyst removalFAERS: 1US FAERS
1413Lupus NephritisFAERS: 1US FAERS
1414LymphadenitisFAERS: 1US FAERS
1415Lymphocyte count decreasedFAERS: 1US FAERS
1416LymphocytosisFAERS: 1US FAERS
1417Lymphoma operationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1418Malabsorption from administration siteFAERS: 1US FAERS
1419Malignant ascitesFAERS: 1US FAERS
1420Malignant neoplasm of thymusFAERS: 1US FAERS
1421MalnutritionFAERS: 1US FAERS
1422Manufacturing issueFAERS: 1US FAERS
1423Manufacturing production issueFAERS: 1US FAERS
1424Marchiafava-Bignami DiseaseFAERS: 1US FAERS
1425MastitisFAERS: 1US FAERS
1426May-Thurner SyndromeFAERS: 1US FAERS
1427Meconium Aspiration SyndromeFAERS: 1US FAERS
1428Medial Tibial Stress SyndromeFAERS: 1US FAERS
1429Medical device site swellingFAERS: 1US FAERS
1430Medical device site thrombosisFAERS: 1US FAERS
1431Meniscus removalFAERS: 1US FAERS
1432Mental disorder due to a general medical conditionFAERS: 1US FAERS
1433Mesangioproliferative glomerulonephritisFAERS: 1US FAERS
1434Mesenteric Vascular OcclusionFAERS: 1US FAERS
1435Metabolic function test abnormalFAERS: 1US FAERS
1436Methylenetetrahydrofolate reductase deficiencyFAERS: 1US FAERS
1437Micrographic skin surgeryFAERS: 1US FAERS
1438Micturition frequency decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1439Migrainous infarctionFAERS: 1US FAERS
1440Monocyte count increasedFAERS: 1US FAERS
1441Mononeuropathy MultiplexFAERS: 1US FAERS
1442Mononucleosis syndromeFAERS: 1US FAERS
1443Motion SicknessFAERS: 1US FAERS
1444Mucosal erosionFAERS: 1US FAERS
1445Multiple System AtrophyFAERS: 1US FAERS
1446Muscle abscessFAERS: 1US FAERS
1447Muscle contusionFAERS: 1US FAERS
1448MutismFAERS: 1US FAERS
1449Mycosis FungoidesFAERS: 1US FAERS
1450Myocardial necrosisFAERS: 1US FAERS
1451Myocardial strainFAERS: 1US FAERS
1452N-terminal prohormone brain natriuretic peptide increasedFAERS: 1US FAERS
1453Nasal pruritusFAERS: 1US FAERS
1454Nasogastric output abnormalFAERS: 1US FAERS
1455Nasopharyngeal surgeryFAERS: 1US FAERS
1456NephritisFAERS: 1US FAERS
1457NephrocalcinosisFAERS: 1US FAERS
1458Neutrophil percentage decreasedFAERS: 1US FAERS
1459Neutrophilic dermatosisFAERS: 1US FAERS
1460Non-high-density lipoprotein cholesterol increasedFAERS: 1US FAERS
1461Noninfectious myelitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1462Nuchal RigidityFAERS: 1US FAERS
1463Obsessive-Compulsive DisorderFAERS: 1US FAERS
1464Ocular HypertensionFAERS: 1US FAERS
1465Ocular vascular disorderFAERS: 1US FAERS
1466Off label use of deviceFAERS: 1US FAERS
1467OligohydramniosFAERS: 1US FAERS
1468OliguriaFAERS: 1US FAERS
1469OnychomycosisFAERS: 1US FAERS
1470Open globe injuryFAERS: 1US FAERS
1471Open reduction of fractureFAERS: 1US FAERS
1472Ophthalmic vein thrombosisFAERS: 1US FAERS
1473Ophthalmologic treatmentFAERS: 1US FAERS
1474OphthalmoplegiaFAERS: 1US FAERS
1475Optic AtrophyFAERS: 1US FAERS
1476Optic NeuritisFAERS: 1US FAERS
1477Oral administration complicationFAERS: 1US FAERS
1478Oral candidiasisFAERS: 1US FAERS
1479Oral contusionFAERS: 1US FAERS
1480Oral mucosal exfoliationFAERS: 1US FAERS
1481Oropharyngeal blisteringFAERS: 1US FAERS
1482Oropharyngeal spasmFAERS: 1US FAERS
1483Orthostatic hypertensionFAERS: 1US FAERS
1484Orthostatic intoleranceFAERS: 1US FAERS
1485Otitis ExternaFAERS: 1US FAERS
1486OtosclerosisFAERS: 1US FAERS
1487Oxygen consumption increasedFAERS: 1US FAERS
1488Oxygen saturation abnormalFAERS: 1US FAERS
1489Palatal ulcerFAERS: 1US FAERS
1490Pancreatic enzymes increasedFAERS: 1US FAERS
1491Panic DisorderFAERS: 1US FAERS
1492ParacentesisFAERS: 1US FAERS
1493Paradoxical drug reactionFAERS: 1US FAERS
1494ParamnesiaFAERS: 1US FAERS
1495Paranasal sinus discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1496Parasite blood test positiveFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1497Partner stressFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1498Paternal exposure timing unspecifiedFAERS: 1US FAERS
1499Pathological fractureFAERS: 1US FAERS
1500Pelvic abscessFAERS: 1US FAERS
1501PemphigusFAERS: 1US FAERS
1502Peptic Ulcer PerforationFAERS: 1US FAERS
1503Performance enhancing product useFAERS: 1US FAERS
1504Pericardial CystFAERS: 1US FAERS
1505PeriodontitisFAERS: 1US FAERS
1506Peripheral arterial reocclusionFAERS: 1US FAERS
1507Peripheral artery angioplastyFAERS: 1US FAERS
1508Peripheral artery bypassFAERS: 1US FAERS
1509Peritoneal DialysisFAERS: 1US FAERS
1510Pharyngeal lesionFAERS: 1US FAERS
1511Physical assaultFAERS: 1US FAERS
1512Plantar erythemaFAERS: 1US FAERS
1513PlasmapheresisFAERS: 1US FAERS
1514Plasmodium vivax infectionFAERS: 1US FAERS
1515Platelet dysfunctionFAERS: 1US FAERS
1516Pneumatosis intestinalisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1517PneumocephalusFAERS: 1US FAERS
1518PneumonectomyFAERS: 1US FAERS
1519PolydipsiaFAERS: 1US FAERS
1520PolyserositisFAERS: 1US FAERS
1521Portal HypertensionFAERS: 1US FAERS
1522Post procedural persistent drain fluidFAERS: 1US FAERS
1523Post procedural pneumoniaFAERS: 1US FAERS
1524Posterior reversible encephalopathy syndromeFAERS: 1US FAERS
1525Postoperative feverFAERS: 1US FAERS
1526Postoperative ileusFAERS: 1US FAERS
1527Postoperative renal failureFAERS: 1US FAERS
1528Postpartum venous thrombosisFAERS: 1US FAERS
1529Postrenal failureFAERS: 1US FAERS
1530PouchitisFAERS: 1US FAERS
1531Prealbumin increasedFAERS: 1US FAERS
1532Precancerous skin lesionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1533Pregnancy of partnerFAERS: 1US FAERS
1534Premenstrual syndromeFAERS: 1US FAERS
1535Prerenal failureFAERS: 1US FAERS
1536Prescription drug used without a prescriptionFAERS: 1US FAERS
1537PriapismFAERS: 1US FAERS
1538Primary Adrenal InsufficiencyFAERS: 1US FAERS
1539Primary headache associated with sexual activityFAERS: 1US FAERS
1540Primary pulmonary melanomaFAERS: 1US FAERS
1541Procedural nauseaFAERS: 1US FAERS
1542Product complaintFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
1543Product contamination physicalFAERS: 1US FAERS
1544Product difficult to swallowFAERS: 1US FAERS
1545Product identification number issueFAERS: 1US FAERS
1546Product monitoring errorFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1547Product name confusionFAERS: 1US FAERS
1548Product preparation errorFAERS: 1US FAERS
1549Product taste abnormalFAERS: 1US FAERS
1550Protein C decreasedFAERS: 1US FAERS
1551Protein C increasedFAERS: 1US FAERS
1552Protein DeficiencyFAERS: 1US FAERS
1553Protein S decreasedFAERS: 1US FAERS
1554Protein total decreasedFAERS: 1US FAERS
1555Pruritus allergicFAERS: 1US FAERS
1556Psoas AbscessFAERS: 1US FAERS
1557Psychiatric decompensationFAERS: 1US FAERS
1558Psychomotor skills impairedFAERS: 1US FAERS
1559Pulmonary endarterectomyFAERS: 1US FAERS
1560Pulmonary function test decreasedFAERS: 1US FAERS
1561Pulmonary vasculitisFAERS: 1US FAERS
1562Pupillary deformityFAERS: 1US FAERS
1563PurulenceFAERS: 1US FAERS
1564PyelocaliectasisFAERS: 1US FAERS
1565PyodermaFAERS: 1US FAERS
1566Radical prostatectomyFAERS: 1US FAERS
1567Rash follicularFAERS: 1US FAERS
1568Reactive gastropathyFAERS: 1US FAERS
1569Rectal ProlapseFAERS: 1US FAERS
1570Rectal dischargeFAERS: 1US FAERS
1571Red blood cell schistocytes presentFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1572Renal aneurysmFAERS: 1US FAERS
1573Renal sympathetic nerve ablationFAERS: 1US FAERS
1574Renal tubular disorderFAERS: 1US FAERS
1575Reperfusion InjuryFAERS: 1US FAERS
1576Respiratory ParalysisFAERS: 1US FAERS
1577Respiratory tract infection bacterialFAERS: 1US FAERS
1578Reticulocyte count abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1579ReticulocytosisFAERS: 1US FAERS
1580Retinal aneurysmFAERS: 1US FAERS
1581Retinal infarctionFAERS: 1US FAERS
1582Revision of internal fixationFAERS: 1US FAERS
1583Rheumatic FeverFAERS: 1US FAERS
1584Rheumatic Heart DiseaseFAERS: 1US FAERS
1585Right Ventricular DysfunctionFAERS: 1US FAERS
1586Rubber sensitivityFAERS: 1US FAERS
1587Ruptured ectopic pregnancyFAERS: 1US FAERS
1588SalpingectomyFAERS: 1US FAERS
1589SarcomaFAERS: 1US FAERS
1590Scan abdomen abnormalFAERS: 1US FAERS
1591Scan abnormalFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
1592Scan myocardial perfusion abnormalFAERS: 1US FAERS
1593Scan with contrast abnormalFAERS: 1US FAERS
1594Schizoaffective DisorderFAERS: 1US FAERS
1595SchizophreniaFAERS: 1US FAERS
1596Sciatic Nerve PalsyFAERS: 1US FAERS
1597Scrotal massFAERS: 1US FAERS
1598Senile dementiaFAERS: 1US FAERS
1599Sensorimotor disorderFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
1600Serous retinal detachmentFAERS: 1US FAERS
1601Shunt occlusionFAERS: 1US FAERS
1602Shunt thrombosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1603Silent myocardial infarctionFAERS: 1US FAERS
1604Single functional kidneyFAERS: 1US FAERS
1605Sinus painFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1606Sinus rhythmFAERS: 1US FAERS
1607Skin discomfortFAERS: 1US FAERS
1608Skin flap necrosisFAERS: 1US FAERS
1609Skin hyperplasiaFAERS: 1US FAERS
1610Skin hypertrophyFAERS: 1US FAERS
1611Skin texture abnormalFAERS: 1US FAERS
1612Sleep ParalysisFAERS: 1US FAERS
1613Sleep TalkingFAERS: 1US FAERS
1614Slow response to stimuliFAERS: 1US FAERS
1615SluggishnessFAERS: 1US FAERS
1616Small cell lung cancer metastaticFAERS: 1US FAERS
1617Small intestine carcinomaFAERS: 1US FAERS
1618SnoringFAERS: 1US FAERS
1619Soft Tissue InfectionFAERS: 1OFFSIDES
US FAERS
1620Soft tissue necrosisFAERS: 1US FAERS
1621Solar lentigoFAERS: 1US FAERS
1622SoliloquyFAERS: 1US FAERS
1623Sperm concentration decreasedFAERS: 1US FAERS
1624Spermatozoa abnormalFAERS: 1US FAERS
1625Spinal StenosisFAERS: 1US FAERS
1626Splenic vein thrombosisFAERS: 1US FAERS
1627Spontaneous penile erectionFAERS: 1US FAERS
1628StaringFAERS: 1US FAERS
1629Steroid therapyFAERS: 1US FAERS
1630Sticky platelet syndromeFAERS: 1US FAERS
1631Streptococcal urinary tract infectionFAERS: 1US FAERS
1632Streptococcus test positiveFAERS: 1US FAERS
1633StridorFAERS: 1US FAERS
1634Stroke in evolutionFAERS: 1US FAERS
1635Subclavian artery embolismFAERS: 1US FAERS
1636Subclavian artery thrombosisFAERS: 1US FAERS
1637Sudden Visual LossFAERS: 1US FAERS
1638Superficial vein prominenceFAERS: 1US FAERS
1639Superinfection bacterialFAERS: 1US FAERS
1640Superior Mesenteric Artery SyndromeFAERS: 1US FAERS
1641Suprapubic painFAERS: 1US FAERS
1642Suspected product quality issueFAERS: 1US FAERS
1643Suture related complicationFAERS: 1US FAERS
1644Synovial fluid crystal presentFAERS: 1US FAERS
1645Temperature intoleranceFAERS: 1US FAERS
1646Tendon discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1647TensionFAERS: 1US FAERS
1648Therapeutic nerve ablationFAERS: 1US FAERS
1649Therapeutic product effect incompleteFAERS: 1US FAERS
1650Therapeutic response changedFAERS: 1US FAERS
1651Therapeutic response delayedFAERS: 1US FAERS
1652Therapeutic skin care topicalFAERS: 1US FAERS
1653Thoracic cavity drainageFAERS: 1US FAERS
1654ThoracostomyFAERS: 1US FAERS
1655ThoracotomyFAERS: 1US FAERS
1656Throat cancerFAERS: 1US FAERS
1657Thrombin time shortenedFAERS: 1US FAERS
1658ThromboembolectomyFAERS: 1US FAERS
1659Thrombosed varicose veinFAERS: 1US FAERS
1660Thymic cancer metastaticFAERS: 1US FAERS
1661ThyroidectomyFAERS: 1US FAERS
1662Toe operationFAERS: 1US FAERS
1663Tongue movement disturbanceFAERS: 1US FAERS
1664Total cholesterol/HDL ratio decreasedFAERS: 1US FAERS
1665Tracheal painFAERS: 1US FAERS
1666Transfusion-Related Acute Lung InjuryFAERS: 1US FAERS
1667Transfusion-related circulatory overloadFAERS: 1US FAERS
1668Ultrasound abdomen abnormalFAERS: 1US FAERS
1669Ultrasound biliary tract abnormalFAERS: 1US FAERS
1670Umbilical herniaFAERS: 1US FAERS
1671Upper airway obstructionFAERS: 1US FAERS
1672UreterolithiasisFAERS: 1US FAERS
1673Urethral ObstructionFAERS: 1US FAERS
1674Urge IncontinenceFAERS: 1US FAERS
1675Urinary control neurostimulator implantationFAERS: 1US FAERS
1676Urinary sediment abnormalFAERS: 1US FAERS
1677Urinary tract infection enterococcalFAERS: 1US FAERS
1678Urinary tract infection fungalFAERS: 1US FAERS
1679Urinary tract infection pseudomonalFAERS: 1US FAERS
1680Urinary tract infection staphylococcalFAERS: 1US FAERS
1681Urine alcohol test positiveFAERS: 1US FAERS
1682Urine flow decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1683Urine viscosity increasedFAERS: 1US FAERS
1684Urodynamics measurement abnormalFAERS: 1US FAERS
1685Uterine PolypFAERS: 1US FAERS
1686Uterine ProlapseFAERS: 1US FAERS
1687UveitisFAERS: 1US FAERS
1688Varicella Zoster Virus InfectionFAERS: 1US FAERS
1689Vascular access site pseudoaneurysmFAERS: 1US FAERS
1690Vascular fragilityFAERS: 1US FAERS
1691Vascular graft complicationFAERS: 1US FAERS
1692Vascular stent occlusionFAERS: 1US FAERS
1693VasospasmFAERS: 1US FAERS
1694Vein collapseFAERS: 1US FAERS
1695Vena cava injuryFAERS: 1US FAERS
1696Venous stent insertionFAERS: 1US FAERS
1697Venous thrombosis in pregnancyFAERS: 1US FAERS
1698Ventricular arrhythmiaFAERS: 1US FAERS
1699Vertebral artery aneurysmFAERS: 1US FAERS
1700Vertebrobasilar InsufficiencyFAERS: 1US FAERS
1701VertebroplastyFAERS: 1US FAERS
1702Vessel puncture site bruiseFAERS: 1US FAERS
1703Vestibular NeuronitisFAERS: 1US FAERS
1704Viral tonsillitisFAERS: 1US FAERS
1705Vitamin B6 decreasedFAERS: 1US FAERS
1706VitiligoFAERS: 1US FAERS
1707Vulvovaginal painFAERS: 1US FAERS
1708Vulvovaginal pruritusFAERS: 1US FAERS
1709White blood cell count abnormalFAERS: 1US FAERS
1710White matter lesionFAERS: 1US FAERS
1711Wound necrosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1712cancer surgeryFAERS: 1US FAERS
1713diagnostic procedureFAERS: 1US FAERS
1714liposarcomaFAERS: 1US FAERS
1715Bilirubin conjugated increasedSIDER
1716Blood and lymphatic system disordersSIDER
1717Blood pressure orthostatic decreasedOFFSIDES
1718Cerebellar microhaemorrhageCanada Vigilance: 1Canada Vigilance
1719Chemical and Drug Induced Liver Injury30719803CTD
1720CholangiolitisOFFSIDES
1721Chronic Obstructive Airway DiseaseOFFSIDES
1722Cytolytic hepatitisSIDER
1723Embolism and Thrombosis16084352CTD
1724Erosive gastritisOFFSIDES
1725Fixed eruptionCanada Vigilance: 1Canada Vigilance
1726HypoperfusionSIDER
1727Idiosyncratic drug reactionCanada Vigilance: 1Canada Vigilance
1728InfestationSIDER
1729Lactic dehydrogenase activity increasedSIDER
1730Liver Cirrhosis30719803CTD
1731MyocarditisCanada Vigilance: 1Canada Vigilance
1732Pharmaceutical product complaintOFFSIDES
1733ProctoscopyCanada Vigilance: 1Canada Vigilance
1734Venous Thromboembolism21995444CTD
SIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.